Anti-IFM1/ IFI™1/CD225 monoclonal antibody

Anti-IFM1/ IFI™1/CD225 antibody for FACS & in-vivo assay

Target products collectionGo to IFI™1/IFI™1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0603-Ab-1/ GM-Tg-hg-MP0603-Ab-2Anti-Human IFI™1 monoclonal antibodyHuman
GM-Tg-rg-MP0603-Ab-1/ GM-Tg-rg-MP0603-Ab-2Anti-Rat IFI™1 monoclonal antibodyRat
GM-Tg-mg-MP0603-Ab-1/ GM-Tg-mg-MP0603-Ab-2Anti-Mouse IFI™1 monoclonal antibodyMouse
GM-Tg-cynog-MP0603-Ab-1/ GM-Tg-cynog-MP0603-Ab-2Anti-Cynomolgus/ Rhesus macaque IFI™1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0603-Ab-1/ GM-Tg-felg-MP0603-Ab-2Anti-Feline IFI™1 monoclonal antibodyFeline
GM-Tg-cang-MP0603-Ab-1/ GM-Tg-cang-MP0603-Ab-2Anti-Canine IFI™1 monoclonal antibodyCanine
GM-Tg-bovg-MP0603-Ab-1/ GM-Tg-bovg-MP0603-Ab-2Anti-Bovine IFI™1 monoclonal antibodyBovine
GM-Tg-equg-MP0603-Ab-1/ GM-Tg-equg-MP0603-Ab-2Anti-Equine IFI™1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0603-Ab-1/ GM-Tg-hg-MP0603-Ab-2; GM-Tg-rg-MP0603-Ab-1/ GM-Tg-rg-MP0603-Ab-2;
GM-Tg-mg-MP0603-Ab-1/ GM-Tg-mg-MP0603-Ab-2; GM-Tg-cynog-MP0603-Ab-1/ GM-Tg-cynog-MP0603-Ab-2;
GM-Tg-felg-MP0603-Ab-1/ GM-Tg-felg-MP0603-Ab-2; GM-Tg-cang-MP0603-Ab-1/ GM-Tg-cang-MP0603-Ab-2;
GM-Tg-bovg-MP0603-Ab-1/ GM-Tg-bovg-MP0603-Ab-2; GM-Tg-equg-MP0603-Ab-1/ GM-Tg-equg-MP0603-Ab-2
Products NameAnti-IFI™1 monoclonal antibody
Formatmab
Target NameIFI™1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IFI™1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species IFM1/ IFI™1/CD225 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP000062human IFI™1 Lentivirus plasmid
    ORF Viral VectorvGMLP000062human IFI™1 Lentivirus particle
    ORF Viral VectorpGMLPm000106mouse Ifitm1 Lentivirus plasmid
    ORF Viral VectorvGMLPm000106mouse Ifitm1 Lentivirus particle


    Target information

    Target IDGM-MP0603
    Target NameIFI™1
    Gene ID8519
    Gene Symbol and Synonyms9-27,CD225,DSPA2a,IFI17,IFI™1,LEU13
    Uniprot AccessionP13164
    Uniprot Entry NameIFM1_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000185885
    Target ClassificationTumor-associated antigen (TAA)

    The target: IFI™1, gene name: IFI™1, also named as 9-27, CD225, DSPA2a, IFI17, LEU13. Interferon-induced transmembrane (IFI™) proteins are a family of interferon induced antiviral proteins. The family contains five members, including IFI™1, IFI™2 and IFI™3 that belong to the CD225 superfamily. The protein encoded by this gene restricts cellular entry by diverse viral pathogens, such as influenza A virus, Ebola virus and Sars-CoV-2. [provided by RefSeq, Nov 2021].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.